The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Efficacy of Pneumococcal Vaccination in Adults: A Meta-analysis of Randomized Controlled Trials
Abstract
BACKGROUND: Because of the prevalence of pneumococcal pneumonia, the substantial morbidity and mortality associated with many pneumococcal infections, and an increase in the incidence of antibiotic resistance among pneumococcal isolates, considerable efforts for disease prevention have been made using a polyvalent polysaccharide pneumococcal vaccine. Despite numerous clinical trials of the vaccine, its efficacy in the prevention of pneumococcal infections and other clinically relevant medical outcomes in adults remains uncertain. METHODS: To assess quantitatively the efficacy of pneumococcal vaccination, a MEDLINE literature search, manual reviews of article bibliographies, and communications with pneumococcal vaccine investigators were used to identify randomized controlled trials of the pneumococcal vaccine. Independent review of 594 articles revealed nine randomized trials with 12 vaccine and control study groups that evaluated clinically relevant outcomes in adults. To estimate a summary effect size for all outcomes, Mantel-Haenszel odds ratios (ORs) and Dersimonian and Laird rate differences (RDs) and their associated 95% confidence intervals (CIs) were computed. RESULTS: Summary ORs demonstrated a statistically significant protective effect of the vaccine for four pneumococcal infection-related outcomes: definitive pneumococcal pneumonia (OR = 0.34; 95% CI = 0.24 to 0.48), definitive pneumococcal pneumonia for vaccine-containing pneumococcal antigen types only (vaccine types only) (OR = 0.17; 95% CI = 0.09 to 0.33), presumptive pneumococcal pneumonia (OR = 0.47; 95% CI = 0.35 to 0.63), and presumptive pneumococcal pneumonia (vaccine types only) (OR = 0.39; 95% CI = 0.26 to 0.59). The summary RDs, which account for heterogeneity among studies, confirmed a statistically significant protective effect for two of these same outcomes: definitive pneumococcal pneumonia (RD = 4/1000; 95% CI = 0/1000 to 7/1000) and definitive pneumococcal pneumonia (vaccine types only) (RD = 8/1000; 95% CI = 1/1000 to 16/1000). Summary ORs and RDs failed to demonstrate a protective effect for pneumonia (all causes), bronchitis, and mortality (all causes) or mortality due to pneumonia or pneumococcal infection. Subgroup analyses showed that for all four pneumococcal infection-related outcomes, vaccine efficacy differed for high- and low-risk subjects, demonstrating efficacy for low-risk subjects and lack of efficacy for high-risk subjects. CONCLUSIONS: Pneumococcal vaccination appears efficacious in reducing bacteremic pneumococcal pneumonia in low-risk adults. However, evidence from randomized controlled trials fails to demonstrate vaccine efficacy for pneumococcal infection-related or other medical outcomes in the heterogeneous group of subjects currently labeled as high risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Statistical Methods for Meta-Analysis
Wasserman, S., Hedges, L. V., & Olkin, I. (1988) · Journal of Educational Statistics · doi:10.2307/1164953 · Cited by 10,326
A method for assessing the quality of a randomized control trial
Chalmers, T. C., Smith, H., Blackburn, B., Silverman, B., Schroeder, B., Reitman, D., & Ambroz, A. (1981) · Controlled Clinical Trials · doi:10.1016/0197-2456(81)90056-8 · Cited by 1,349
Meta-Analysis in Clinical Research
L'ABBÉ, K. A., DETSKY, A. S., & O'ROURKE, K. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-224 · Cited by 1,267
Meta-Analyses of Randomized Controlled Trials
Sacks, H. S., Berrier, J., Reitman, D., Ancona-Berk, V. A., & Chalmers, T. C. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702193160806 · Cited by 1,250
The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide Vaccine
Shapiro, E. D., Berg, A. T., Austrian, R., Schroeder, D., Parcells, V., Margolis, A., Adair, R. K., & Clemens, J. D. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252101 · Cited by 1,051
Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations
Butler, J. C. (1993) · JAMA · doi:10.1001/jama.270.15.1826 · Cited by 671
Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-720_2 · Cited by 543
PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES
MacLeod, C. M., Hodges, R. G., Heidelberger, M., & Bernhard, W. G. (1945) · Journal of Experimental Medicine · doi:10.1084/jem.82.6.445 · Cited by 518
7. Prevention of Pneumococcal Pneumonia by Vaccination
Austrian, R., Douglas, R. M., Schiffman, G., Coetzee, A. M., Koornhof, H. J., Hayden-Smith, S., & Reid, R. D. W. (1985) · Life with the Pneumococcus · doi:10.9783/9781512800135-009 · Cited by 401
Efficacy of Pneumococcal Vaccine in High-Risk Patients
Simberkoff, M. S., Cross, A. P., Al-Ibrahim, M., Baltch, A. L., Geiseler, P. J., Nadler, J., Richmond, A. S., Smith, R. P., Schiffman, G., Shepard, D. S., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611203152104 · Cited by 395
Thymus-Independent and Thymus-Dependent Responses to Polysaccharide Antigens
Stein, K. E. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/165-supplement_1-s49 · Cited by 377
Protective Efficacy of Pneumococcal Polysaccharide Vaccines
Smit, P. (1977) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1977.03280250039019 · Cited by 350
The Clinical Effectiveness of Pneumococcal Vaccine in the Elderly
SIMS, R. V., STEINMANN, W. C., MCCONVILLE, J. H., KING, L. R., ZWICK, W. C., & SCHWARTZ, J. S. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-5-653 · Cited by 317
Pneumococcal Vaccine Efficacy in Selected Populations in the United States
BOLAN, G., BROOME, C. V., FACKLAM, R. R., PLIKAYTIS, B. D., FRASER, D. W., & SCHLECH, W. F. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-1-1 · Cited by 261
SHAPIRO, E. D., & CLEMENS, J. D. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-3-325 · Cited by 259
Pneumococcal bacteremia in Charleston County, South Carolina. A decade later
Breiman, R. F. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.7.1401 · Cited by 216
IMMUNISATION WITH A POLYVALENT PNEUMOCOCCAL VACCINE
Riley, I. D., Andrews, M., Howard, R., Tarr, P. I., Pfeiffer, M., Challands, P., Jennison, G., & Douglas, R. M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92552-1 · Cited by 184
Inefficacy of pneumococcal vaccine in a high-risk population
Forrester, H. L., Jahnigen, D. W., & Marc Laforce, F. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90751-0 · Cited by 168
Rodriguez‐Barradas, M. C., Musher, D. M., Lahart, C., Lacke, C. E., Groover, J. E., WATSON, D. A., BAUGHN, R. E., Cate, T. R., & Crofoot, G. E. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/165.3.553 · Cited by 151
Clinical and epidemiologic studies of pneumococcal infection in children
Gray, B. M., & Dillon, H. C. (1986) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198603000-00009 · Cited by 139
Pneumococcal Vaccine: Clinical Efficacy and Effectiveness
Schwartz, J. S. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-2-208 · Cited by 138
Kaufman, P. (1947) · Archives of Internal Medicine · doi:10.1001/archinte.1947.00220110058004 · Cited by 123
Response of Patients with Hodgkin's Disease to Pneumococcal Vaccine
Minor, D. R., Schiffman, G., & McINTOSH, L. S. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-6-887 · Cited by 118
[Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions].
GAILLAT, J., Zmirou‐Navier, D., Mallaret, M., Rouhan, D., Bru, J. P., Stahl, J. ‐., Delormas, P., & Micoud, M. (1985) · PubMed · Cited by 115
Davis, A. L., Aranda, C. P., Schiffman, G., & Christianson, L. C. (1987) · CHEST Journal · doi:10.1378/chest.92.2.204 · Cited by 103
Revaccination of Renal Transplant and Hemodialysis Recipients With Pneumococcal Vaccine
Linnemann, C. C. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360200116019 · Cited by 100
(1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-6-882_1 · Cited by 95
Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease.
Leech, J., Gervais, A., & Ruben, F. L. (1987) · Europe PMC (PubMed Central) · Cited by 88
Pneumococcal vaccination: The response of patients with multiple myeloma
Lazarus, H. M., Lederman, M. M., Lubin, A., Herzig, R. H., Schiffman, G., Jones, P. K., Wine, A., & Rodman, H. M. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90014-5 · Cited by 76
Pneumococcal Vaccine in the United States: A Critical Analysis
Hirschmann, J. V. (1981) · JAMA · doi:10.1001/jama.1981.03320130034020 · Cited by 70
Jacobs, N. M., Lerdkachornsuk, S., & Metzger, W. I. (1979) · PEDIATRICS · doi:10.1542/peds.64.3.296 · Cited by 62
Glaser, J. B., Volpe, S., Aguirre, A., Simpkins, H., & Schiffman, G. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/164.4.761 · Cited by 62
A critical review of adult health maintenance. Part 1: Prevention of atherosclerotic diseases.
Ps, F. (1986) · PubMed · Cited by 51
Placebo controlled pneumococcal immunization in patients with bronchogenic carcinoma
Klastersky, J., Mommen, P., Cantraine, F. R. L., & Safary, A. (1986) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(86)90367-6 · Cited by 46
Immunizations, Immunoprophylaxis, and Chemoprophylaxis to Prevent Selected Infections
LaForce, F. M. (1987) · JAMA · doi:10.1001/jama.1987.03390180082028 · Cited by 42
Pneumococcal capsular polysaccharide vaccination in adult chronic hemodialysis patients.
Ms, S., Schiffman, G., Katz, L. A., Spicehandler, J., Nh, M., & Jj, R. (1980) · PubMed · Cited by 36
PNEUMOCOCCAL VACCINE IN ABORIGINAL CHILDREN—A RANDOMIZED CONTROLLED TRIAL INVOLVING 60 CHILDREN
Douglas, R. M., Hansman, D., McDonald, B., Paton, J. C., & Kirke, K. D. (1986) · Community Health Studies · doi:10.1111/j.1753-6405.1986.tb00099.x · Cited by 27
WHO Recommendations on Pneumococcal Vaccination
Fedson, D. S., Henrichsen, J., Mfikel, P. H., & AUSTRIAN, R. C. (1989) · Cited by 7
Pneumococcal polysaccharide vaccine prevents death from pneumonia in Papua New Guinean children.
Lehmann, D. (1986) · PubMed · Cited by 6
Cited by
Hao (2015) · doi:10.1002/14651858 · Cited by 11,321
Social Relationships and Mortality Risk: A Meta-analytic Review
Holt-Lunstad, J., Smith, T. B., & Layton, J. B. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000316 · Cited by 7,272
“The effect sizes were estimated from meta analyses: ; A = Shavelle, Paculdo, Strauss, and Kush, 2008 [205]; B = Critchley and Capewell, 2003 [206]; C = Holman, English, Milne, and Winter, 1996 [207]; D = Fine, Smith, Carson, Meffe, Sankey, Weissfeld, Detsky, and Kapoor, 1994 [208]; E = Taylor, Brown, Ebrahim, Jollife,…”
Prognosis and Outcomes of Patients With Community-Acquired Pneumonia: A Meta-analysis
Fine, M. J. (1996) · JAMA · doi:10.1001/jama.1996.03530260048030 · Cited by 1,310
Self-citationAdvancing social connection as a public health priority in the United States.
Holt-Lunstad, J., Robles, T. F., & Sbarra, D. A. (2017) · American Psychologist · doi:10.1037/amp0000103 · Cited by 978
Vaccines for preventing pneumococcal infection in adults
Moberley, S., Holden, J., Tatham, D. P., & Andrews, R. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000422.pub3 · Cited by 960
Metadata
- Authors
- Fine, M. J.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 1994-12-12
- Volume
- 154
- Issue
- 23
- Pages
- 2666
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2008004063
- Cited by
- 370
- References
- 40
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.